NS5A inhibitors (Pfizer)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameNS5A inhibitors (Pfizer)

Drug Alias NamePF-5071436PF-5191141

ClassificationSmall molecules

Mechanisms of ActionNonstructural protein 5A inhibitors

TargetsNonstructural protein 5A

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsHepatitis C

ATC CodeN/A